top of page
Cluster News
Deeptech in Glioblastoma
On January 22, 2026, the PSCC and Brain&Mind jointly brought together, at The Hive building on Campus Grand Parc (Villejuif), a broad range of stakeholders involved in innovation in glioblastoma — clinicians, researchers, biotech, medtech and pharmaceutical companies, patients and patient representatives, as well as institutional stakeholders. The objective of this event was to take stock of the latest advances in glioblastoma, to discuss future perspectives from technologica
Jan 22
Lunch & Learn – Speed up blood cancer research with high value added biological resources
On November 27, 2025, the Lunch & Learn event – " Speed up blood cancer research with high value added biological resources" – took place , featuring Emilie Robert, Head of Strategy and Valorization at CRYOSTEM . The replay is now available. Access the replay View the presentation
Nov 28, 2025
Lunch & Learn – Translational Mechanistic Modeling: Applications for Antibody Drug Conjugates (ADCs)
On October 2, 2025, the Lunch & Learn – Translational Mechanistic Modeling: Applications for Antibody Drug Conjugates (ADCs) took place , with Séverine Urdy, PhD – Scientific Lead, Biologics Modeling and Simulation at PhinC Development, the replay is now available Access the replay Check out the presentation
Oct 13, 2025
Symposium: Digital twins in oncology
The replay of the symposium: Digital twins in oncology is available! Throughout the day, keynotes, panel discussions, and workshops...
Jul 17, 2025
PSCC Explore: Targeted Protein Degradation for cancer therapy : Protacs & Molecular Glues
The first PSCC Explore took place on 16 May 2025. 🔹 First Talk – 10:00 AM (45 min): Prof. Alessio Ciulli Professor of Chemical...
May 27, 2025
Hack4Hope: Together for Children With Cancer
The Paris-Saclay Cancer Cluster (PSCC), the PSCC Childhood Cancer Working Group, and Imagine for Margo are happy to organize the...
Oct 30, 2024
Cluster News
In Villejuif, the Paris-Saclay Cancer Cluster deploys an operational model to accelerate innovation in oncology
Villejuif, February 4, 2026 - On World Cancer Day , the Paris-Saclay Cancer Cluster (PSCC) is hosting the 3rd edition of its PSCC Innovation Forum in Villejuif. More than 700 oncology stakeholders -researchers, clinicians, start-ups, industrial players, investors, and patient representatives - are gathering around a shared conviction: t he future of oncology now lies in the ability to rapidly translate scientific innovation into tangible clinical impact. Each year, nearly 4
Feb 4
(In French) Hack4Hope 2025 : Ensemble pour transformer la prise en charge des cancers pédiatriques
Une deuxième édition ambitieuse dédiée aux cancers de l’enfant et de l’adolescent , organisée par le PSCC et son Childhood Cancer Working Group, avec le soutien de LifeArc, Foundation S, Imagine for Margo, Sanofi et Bristol Myers Squibb. 9 projets finalistes sélectionnés parmi 24 candidatures, couvrant thérapies innovantes, IA, diagnostics, nanomédecine et soutien aux familles. 4 gagnants distingués par le jury : Kindling Bio (1er Prix), MSInsight (2e Prix), Hippoxis (3e Pr
Dec 5, 2025
(In French) À The Hive, le Central Lab et l’Innovation Center dévoilent leur offre aux sociétés innovantes en oncologie du PSCC
Premier événement scientifique organisé au sein de The Hive , bâtiment totem du biocluster, au cœur du Campus Grand Parc Lancement du Central Lab , bientôt opérationnel pour accompagner les projets précliniques et cliniques Déploiement de l’ Innovation Center , une offre modulable destinée aux jeunes start-ups Présentation de deux nouveaux locataires de The Hive : Valerio Therapeutics , et Signadori Bio Villejuif, le 04 décembre 2025 – Organisée à The Hive, bâtiment de 25
Dec 4, 2025
(in french) Déploiement du système robotique ION : La biopsie robot-assistée qui révolutionne le traitement et le diagnostic du cancer du poumon est en place à l’Hôpital Marie-Lannelongue
Paris, France, 11 septembre, 2025 — L’Hôpital Marie-Lannelongue, le Centre International des Cancers Thoraciques (CICT) et le Paris...
Sep 12, 2025
Cluster News
Pediatric Cancers: what to anticipate and what ressources are available
An exclusive webinar led by Pr. GILLES VASSAL, Pediatric Oncologist at Gustave Roussy, and member of ITCC Consortium, on « 𝙋𝙚𝙙𝙞𝙖𝙩𝙧𝙞𝙘 𝘾𝙖𝙣𝙘𝙚𝙧𝙨 : 𝙬𝙝𝙖𝙩 𝙩𝙤 𝙖𝙣𝙩𝙞𝙘𝙞𝙥𝙖𝙩𝙚 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙧𝙚𝙨𝙨𝙤𝙪𝙧𝙘𝙚𝙨 𝙖𝙧𝙚 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚 ? »
3 days ago
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
Apr 7
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
Cluster News
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
New start-ups join the PSCC BOOST programme
For the beginning of 2026, five innovative oncology-focused projects were successful in the selection process and join the BOOST programme of the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From novel therapeutic modalities to next-generation biologics , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of breakthrough science into tangible imp
Jan 7
9 new projects supported by the PSCC
From diagnosis to therapies, from molecules to algorithms: innovation takes multiple forms within the Paris Saclay Cancer Cluster (PSCC)....
Sep 25, 2025
8 new projects to be supported by the PSCC
We are thrilled to announce that 5 new projects have been selected by the PSCC to benefit from its support: Carla Biotherapeutics : A...
Jun 23, 2025
Cluster News
Les Echos - A Villejuif, le cluster de l'oncologie prend de l'ampleur (in french)
Huit entreprises, 250 salariés et un fonds de subvention de 2,5 millions d'euros… Le Paris-Saclay Cancer Cluster met les bouchées doubles à Villejuif pour accélérer le passage de la recherche à la fabrication de traitement contre le cancer. Le Paris-Saclay Cancer Cluster met les bouchées doubles. Ce cluster, financé par l'Etat à hauteur de 100 millions d'euros, développe un pôle consacré à l'oncologie et à la déclinaison de la recherche en traitement pour trouver des solution
Feb 6
Mind Health - Le PSCC dévoile ses ambitions pour 2026 (in French)
Le Paris-Saclay Cancer Cluster (PSCC), le biocluster dédié à l'oncologie, a présenté le 4 février un bilan de son activité depuis sa création en 2022 à l'occasion du PSCC Innovation Forum 2026. Son Campus, doté d'un investissement de 1,8 Mds €, sort progressivement de terre : 45 000 m² de laboratoires et de bureaux sont opérationnels depuis 2025. En janvier, sept entreprises, dont Sanofi et One Biosciences, ont déjà rejoint le cluster et le PSCC vise l'installation de plus de
Feb 6
L'Express - Visite exclusive au cœur du "Paris-Saclay Cancer Cluster" : "Grâce à cet incubateur, tout va plus vite (in french)
Reportage. Sous l’impulsion d’Emmanuel Macron, la France tente d’ériger à Villejuif un incubateur géant pour aider les scientifiques à transformer leurs idées en médicaments. C'est vrai que l'on s’y perd dans ces couloirs où rien n’est indiqué, au milieu de toutes ces salles nues, qui attendent encore qu’on les habille de meubles et de moquettes. Le "Paris-Saclay Cancer Cluster", projet d’incubateur inédit en France, n’est pas tout à fait fini, et cela se devine à tous ces sa
Feb 3
L'Express - Cancer, les vrais progrès de la science : "La frontière de la guérison a bougé"
Sciences et santé. Les médecins arrivent désormais à prolonger la vie de certains patients atteints de tumeurs métastatiques. Une révolution, même si le cancer reste la première cause de décès dans notre pays. On dit de Valérie, 56 ans, qu’elle a "bonne mine". Qu’elle n’a pas l’air "malade". Peut-être est-ce dû à cet infatigable entrain, elle qui a toujours eu une énergie "débordante" et mille projets à la fois, cadre dans l’assurance et élue d’une petite commune du sud de la
Nov 26, 2025
Cluster News
Pediatric Cancers: what to anticipate and what ressources are available
An exclusive webinar led by Pr. GILLES VASSAL, Pediatric Oncologist at Gustave Roussy, and member of ITCC Consortium, on « 𝙋𝙚𝙙𝙞𝙖𝙩𝙧𝙞𝙘 𝘾𝙖𝙣𝙘𝙚𝙧𝙨 : 𝙬𝙝𝙖𝙩 𝙩𝙤 𝙖𝙣𝙩𝙞𝙘𝙞𝙥𝙖𝙩𝙚 𝙖𝙣𝙙 𝙬𝙝𝙖𝙩 𝙧𝙚𝙨𝙨𝙤𝙪𝙧𝙘𝙚𝙨 𝙖𝙧𝙚 𝙖𝙫𝙖𝙞𝙡𝙖𝙗𝙡𝙚 ? »
3 days ago
Standardize and scale tumor organoids to accelerate innovation in oncology.
On April 7, 2026, the Ecosystem Breakfast took place on the theme " Standardize and scale tumor organoids to accelerate innovation in oncology"; the replay is now available. With : Benjamin Saulnier: CEO of Cellura (SoftCell Therapeutics) . Access the replay
Apr 7
Understanding innovative purchasing in hospitals with the RESAH
Understanding innovative purchasing in hospitals with the RESAH
Mar 27
New start-ups join the PSCC BOOST programme
Five innovative oncology-focused projects have been selected through the BOOST programme and join the Paris Saclay Cancer Cluster (PSCC), further strengthening the diversity, scientific excellence and ambition of the ecosystem. From cell therapies to gene delivery, theranostics, vaccines and advanced imaging technologies , these projects illustrate the breadth of approaches supported by PSCC to accelerate the translation of scientific breakthroughs into tangible impact for p
Mar 25
bottom of page